Taiwan Biomaterial , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow5.15%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Taiwan Biomaterial , Ltd.'s return on equity stands at 5.15%. That is below the sector sector average of 11.64%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Taiwan Biomaterial , Ltd. sits lower the its sector benchmark (11.64%) with a ROE of 5.15%. That is roughly 55.7% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 5.15% for Taiwan Biomaterial , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Taiwan Biomaterial , Ltd.'s ROE evolved across reporting periods, while the comparison chart places 6649.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
